Intraocular Lens Injectors Market Size

  • Report ID: 6032
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Intraocular Lens Injectors Market size was over USD 16.43 billion in 2024 and is projected to reach USD 31.76 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of intraocular lens injectors is assessed at USD 17.16 billion.

This growth of the intraocular lens injectors market is assessed to be encouraged by the growing prevalence of cataracts. As per the estimation of the World Health Organization, above 2.2 billion individuals are suffering from near or distant vision impairment. Out of these numbers, over 1 billion people are set to have cataracts. Hence, in order to insert the folded lens in the patient's eyes a tool is needed further to reduce the patient's trauma during surgery. As a result, intraocular lens is considered to be the best tool in cataract surgery. 


Intraocular Lens Injectors Market overviews

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of intraocular lens injectors is assessed at USD 17.16 billion.

The intraocular lens injectors market size was over USD 16.43 billion in 2024 and is projected to reach USD 31.76 billion by 2037, witnessing around 5.2% CAGR during the forecast period i.e., between 2025-2037. The market growth is propelled by growing prevalence of cataracts.

North America industry is poised to account for largest revenue share of 30% by 2037, influenced by growing prevalence ophthalmic disorders in the region.

The major players in the market are SpyGlass Pharma, Alcon, Bausch Health Companies, Inc., Carl Zeiss AG, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos